BCL2 and neoplasm: The tumour exhibited a CD20+, CD79a+, CD 10+, immunophenotype, Bcl-2 focal positivity, Ki-67 >90% positivity, whereas other markers were negative including CD3, CD45RO, CD15, CD30, ALK and EMA.